[Gastroenterology and hepatology: what's new in 2022].

Abstract

The field of gastroenterology and hepatology is evolving constantly. In 2022, numerous landmark studies have been published in all its subspecialities including hepatology, functional diseases, interventional endoscopy, and inflammatory bowel disease. Among the most significant advances are the antiviral treatment for hepatitis D, the new Chicago classification version 4 for esophageal motility disorders, the first biological treatment for eosinophilic esophagitis, a randomized controlled trial about the efficacy of screening colonoscopy, novel endoscopic techniques such as G-POEM or endoscopic sleeve gastrectomy, and emerging IBD therapies such as ozanimod, upadacitinib or anti-IL23 antibodies.

• Authors: Montserrat Fraga, Céline Ghaoui, Gian-Marco Stamm, Alain Schoepfer, Thomas Greuter
• Journal: Revue medicale suisse (Rev Med Suisse) Vol. 19 Issue 812 Pg. 217-220 (Feb 01 2023) ISSN: 1660-9379 [Print] Switzerland
• Vernacular Title: Gastroentérologie et hépatologie : ce qui a changé en 2022.
• PMID: 36723651 (Publication Type: English Abstract, Journal Article)

Topics

• Humans
• Gastroenterology (methods)
• Inflammatory Bowel Diseases (therapy)
• Colonoscopy